A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia
- PDF / 1,793,291 Bytes
- 9 Pages / 595.276 x 790.866 pts Page_size
- 55 Downloads / 147 Views
RESEARCH
Open Access
A modified microchip-based flow chamber system for evaluating thrombogenicity in patients with thrombocytopenia Bengo Atari1, Takashi Ito2* , Tomoka Nagasato3, Tomoko Ohnishi3, Kazuya Hosokawa3, Tomotsugu Yasuda1, Ikuro Maruyama2 and Yasuyuki Kakihana1
Abstract Background: In the intensive care unit (ICU), patients with thrombocytopenia are at high risk for bleeding and should be assessed for their thrombogenic potential. However, the analytical conditions of conventional hemostatic tests are unsuitable for the evaluation of low-platelet samples. Here we aimed to establish suitable analytical conditions with the Total Thrombus-formation Analysis System (T-TAS) for quantitative assessment of thrombogenic potential in patients with thrombocytopenia and to investigate how T-TAS values relate to bleeding symptoms and the effects of platelet transfusion. Methods: Modified chips with a different chamber depth were developed for the analysis of low-platelet samples in the T-TAS. We included 10 adult patients admitted to the ICU of Kagoshima University Hospital who required platelet transfusion. Patients were divided into major and minor bleeding groups according to their bleeding scale before platelet transfusion. The thrombogenic potential of these patients before and after platelet transfusion was assessed with hemostatic function tests, including rotational thromboelastometry, multiplate aggregometry, and the T-TAS. Results: Analysis of low-platelet samples revealed that, compared with the conventional chip (80-μm-deep chamber), the modified chip (50-μm-deep chamber) achieved higher sensitivity in detecting elevation of flow pressure caused by growth of an occlusive thrombus in the T-TAS analytical chamber. All patients in the minor bleeding group retained thrombogenic potential that occluded the modified chip (occlusion time 16.3 ± 3.3 min), whereas most patients in the major bleeding group were unable to occlude the modified chip during the 30-min measurement (P < 0.01). The recovery of thrombogenic potential after platelet transfusion was confirmed with the T-TAS and correlated with the function, rather than the count, of transfused platelets. Among all evaluated parameters in hemostatic function tests, only the T-TAS showed significant differences in occlusion time and area under the curve both between the minor and major bleeding groups and between pre- and post-platelet transfusion. Conclusions: We developed a modified microchip-based flow chamber system that reflects the hemostatic function of patients with thrombocytopenia. Keywords: Thrombocytopenia, Platelet transfusion, Bleeding, Flow chamber, Total Thrombus-formation analysis system (T-TAS)
* Correspondence: [email protected] 2 Department of Systems Biology in Thromboregulation, Kagoshima University Graduate School of Medical and Dental Sciences, 8-35-1 Sakuragaoka, Kagoshima 890-8544, Japan Full list of author information is available at the end of the article © The Author(s). 2020 Open Access This article is licens
Data Loading...
